Phoebe Hildreth Yager, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intensive Care Units, Pediatric | 15 | 2021 | 981 | 2.450 |
Why?
|
Telemedicine | 8 | 2020 | 2872 | 1.010 |
Why?
|
Teaching Rounds | 2 | 2020 | 253 | 0.990 |
Why?
|
Critical Care | 7 | 2023 | 2647 | 0.900 |
Why?
|
Hyperkalemia | 2 | 2021 | 218 | 0.760 |
Why?
|
Saline Solution, Hypertonic | 1 | 2020 | 110 | 0.690 |
Why?
|
Professional-Family Relations | 2 | 2020 | 482 | 0.660 |
Why?
|
Naloxone | 1 | 2021 | 367 | 0.660 |
Why?
|
Hospitals, Pediatric | 4 | 2023 | 1775 | 0.630 |
Why?
|
Hyponatremia | 1 | 2021 | 298 | 0.620 |
Why?
|
Intracranial Pressure | 1 | 2020 | 326 | 0.610 |
Why?
|
Intracranial Hypertension | 1 | 2020 | 186 | 0.600 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 407 | 0.570 |
Why?
|
Emergency Medicine | 3 | 2017 | 1207 | 0.570 |
Why?
|
Hospital Rapid Response Team | 1 | 2016 | 57 | 0.530 |
Why?
|
Documentation | 1 | 2021 | 871 | 0.510 |
Why?
|
Videoconferencing | 1 | 2017 | 195 | 0.500 |
Why?
|
Heparin | 1 | 2022 | 1637 | 0.490 |
Why?
|
Sodium | 1 | 2020 | 1623 | 0.490 |
Why?
|
Manikins | 2 | 2017 | 238 | 0.490 |
Why?
|
Patient Care Team | 6 | 2020 | 2531 | 0.480 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2014 | 56 | 0.480 |
Why?
|
Babesia microti | 1 | 2014 | 31 | 0.470 |
Why?
|
Babesiosis | 1 | 2014 | 92 | 0.440 |
Why?
|
Tachycardia, Ventricular | 1 | 2021 | 1273 | 0.420 |
Why?
|
Pediatrics | 5 | 2020 | 3475 | 0.420 |
Why?
|
After-Hours Care | 1 | 2012 | 102 | 0.400 |
Why?
|
Blood | 1 | 2014 | 598 | 0.400 |
Why?
|
Intensive Care Units | 3 | 2023 | 3679 | 0.390 |
Why?
|
Neurologic Examination | 1 | 2014 | 930 | 0.380 |
Why?
|
Child | 30 | 2024 | 77709 | 0.370 |
Why?
|
Shock | 2 | 2021 | 318 | 0.350 |
Why?
|
Foramen Ovale, Patent | 1 | 2012 | 223 | 0.350 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3843 | 0.340 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2376 | 0.330 |
Why?
|
Physical Examination | 1 | 2014 | 1237 | 0.320 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2022 | 612 | 0.310 |
Why?
|
Mannose-Binding Lectin | 1 | 2008 | 150 | 0.290 |
Why?
|
Thromboembolism | 1 | 2012 | 986 | 0.270 |
Why?
|
Curriculum | 4 | 2024 | 3605 | 0.270 |
Why?
|
Airway Management | 3 | 2021 | 329 | 0.270 |
Why?
|
Quality Improvement | 2 | 2021 | 3749 | 0.260 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.240 |
Why?
|
Anemia | 1 | 2014 | 1506 | 0.240 |
Why?
|
Parents | 2 | 2019 | 3407 | 0.240 |
Why?
|
Infant | 14 | 2021 | 35136 | 0.230 |
Why?
|
Intubation, Intratracheal | 3 | 2021 | 1364 | 0.230 |
Why?
|
Multilingualism | 1 | 2024 | 87 | 0.230 |
Why?
|
Boston | 5 | 2020 | 9313 | 0.220 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2274 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Cities | 1 | 2023 | 513 | 0.190 |
Why?
|
Reperfusion Injury | 1 | 2008 | 1026 | 0.190 |
Why?
|
Waste Management | 1 | 2020 | 19 | 0.190 |
Why?
|
Physicians | 1 | 2019 | 4567 | 0.190 |
Why?
|
Otolaryngology | 2 | 2020 | 645 | 0.190 |
Why?
|
Respiratory System | 2 | 2020 | 557 | 0.180 |
Why?
|
Organizational Policy | 2 | 2020 | 429 | 0.180 |
Why?
|
Child, Preschool | 12 | 2021 | 41006 | 0.170 |
Why?
|
Drug Dosage Calculations | 1 | 2020 | 114 | 0.170 |
Why?
|
Bioethical Issues | 1 | 2020 | 124 | 0.170 |
Why?
|
Containment of Biohazards | 1 | 2019 | 37 | 0.170 |
Why?
|
Bioethics | 1 | 2020 | 116 | 0.170 |
Why?
|
Humans | 43 | 2024 | 744343 | 0.170 |
Why?
|
Brain Injuries | 2 | 2008 | 2025 | 0.170 |
Why?
|
Critical Illness | 4 | 2022 | 2670 | 0.160 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 170 | 0.160 |
Why?
|
Dexmedetomidine | 2 | 2014 | 315 | 0.160 |
Why?
|
Inservice Training | 1 | 2019 | 392 | 0.140 |
Why?
|
Adolescent | 13 | 2021 | 85781 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2021 | 652 | 0.140 |
Why?
|
Outsourced Services | 1 | 2016 | 21 | 0.140 |
Why?
|
Narcotic Antagonists | 1 | 2021 | 562 | 0.140 |
Why?
|
Hospital Administration | 1 | 2020 | 353 | 0.140 |
Why?
|
Angiography | 1 | 2022 | 1639 | 0.140 |
Why?
|
Rabies Vaccines | 1 | 2015 | 31 | 0.130 |
Why?
|
Rabies virus | 1 | 2015 | 39 | 0.130 |
Why?
|
Transportation of Patients | 1 | 2016 | 185 | 0.130 |
Why?
|
Respiratory Therapy | 1 | 2015 | 132 | 0.130 |
Why?
|
Rabies | 1 | 2015 | 61 | 0.130 |
Why?
|
Emergency Treatment | 1 | 2019 | 517 | 0.120 |
Why?
|
Hypnotics and Sedatives | 2 | 2014 | 1162 | 0.120 |
Why?
|
Postoperative Care | 2 | 2011 | 1486 | 0.120 |
Why?
|
Medical Records | 1 | 2020 | 1413 | 0.120 |
Why?
|
Tick-Borne Diseases | 1 | 2014 | 34 | 0.120 |
Why?
|
Environment | 1 | 2020 | 1124 | 0.120 |
Why?
|
Male | 20 | 2021 | 350118 | 0.120 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2019 | 428 | 0.110 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1504 | 0.110 |
Why?
|
Dysarthria | 1 | 2012 | 57 | 0.110 |
Why?
|
Female | 18 | 2022 | 380194 | 0.110 |
Why?
|
Hypokalemia | 1 | 2013 | 153 | 0.100 |
Why?
|
Retrospective Studies | 10 | 2022 | 77449 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2107 | 0.100 |
Why?
|
Basilar Artery | 1 | 2012 | 200 | 0.100 |
Why?
|
Patient Transfer | 2 | 2016 | 761 | 0.100 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 695 | 0.100 |
Why?
|
Infection Control | 1 | 2019 | 966 | 0.100 |
Why?
|
Delivery of Health Care | 3 | 2024 | 5319 | 0.100 |
Why?
|
Brain Death | 2 | 2012 | 348 | 0.100 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1354 | 0.100 |
Why?
|
Communication | 2 | 2017 | 3749 | 0.090 |
Why?
|
Vomiting | 1 | 2014 | 636 | 0.090 |
Why?
|
Hypovolemia | 1 | 2010 | 45 | 0.090 |
Why?
|
Homocystinuria | 1 | 2010 | 67 | 0.090 |
Why?
|
Ataxia | 1 | 2012 | 304 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2073 | 0.090 |
Why?
|
Stroke | 1 | 2012 | 9981 | 0.090 |
Why?
|
Quality Control | 1 | 2012 | 841 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2019 | 1772 | 0.080 |
Why?
|
Pilot Projects | 3 | 2017 | 8324 | 0.080 |
Why?
|
Liver Failure, Acute | 1 | 2010 | 165 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2518 | 0.080 |
Why?
|
Adult | 7 | 2023 | 214055 | 0.080 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2569 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4669 | 0.080 |
Why?
|
Coma | 1 | 2012 | 475 | 0.080 |
Why?
|
Patient Simulation | 1 | 2011 | 309 | 0.080 |
Why?
|
Observer Variation | 1 | 2014 | 2593 | 0.080 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2016 | 980 | 0.080 |
Why?
|
Hospitalists | 1 | 2012 | 305 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12959 | 0.080 |
Why?
|
Leukoencephalopathies | 1 | 2010 | 238 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2400 | 0.080 |
Why?
|
Death | 1 | 2012 | 678 | 0.080 |
Why?
|
Problem-Based Learning | 1 | 2011 | 361 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2017 | 5078 | 0.070 |
Why?
|
Complement C4 | 1 | 2007 | 257 | 0.070 |
Why?
|
Fever | 1 | 2014 | 1616 | 0.070 |
Why?
|
Developing Countries | 2 | 2020 | 2815 | 0.070 |
Why?
|
Brain Edema | 2 | 2008 | 617 | 0.070 |
Why?
|
Fluid Therapy | 1 | 2010 | 593 | 0.070 |
Why?
|
Larynx | 1 | 2010 | 494 | 0.070 |
Why?
|
Respiratory Tract Diseases | 1 | 2011 | 722 | 0.070 |
Why?
|
Complement Activation | 1 | 2008 | 453 | 0.070 |
Why?
|
Complement C3 | 1 | 2008 | 461 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 950 | 0.070 |
Why?
|
Skin Diseases | 1 | 2014 | 1065 | 0.060 |
Why?
|
Vision Disorders | 1 | 2012 | 1058 | 0.060 |
Why?
|
Prospective Studies | 5 | 2017 | 53288 | 0.060 |
Why?
|
Shock, Cardiogenic | 1 | 2010 | 688 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15540 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3396 | 0.060 |
Why?
|
Tissue and Organ Procurement | 1 | 2012 | 896 | 0.060 |
Why?
|
Checklist | 1 | 2011 | 833 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 423 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2015 | 2119 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2015 | 3176 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1177 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8388 | 0.060 |
Why?
|
Shock, Septic | 1 | 2010 | 775 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2020 | 25625 | 0.060 |
Why?
|
Terminology as Topic | 1 | 2010 | 1547 | 0.060 |
Why?
|
Heart Rate | 1 | 2014 | 4091 | 0.050 |
Why?
|
Biosensing Techniques | 1 | 1988 | 668 | 0.050 |
Why?
|
Cell Death | 1 | 2008 | 1706 | 0.050 |
Why?
|
Acute Disease | 1 | 2012 | 7149 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2759 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2015 | 3110 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 7023 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7659 | 0.050 |
Why?
|
Medical Waste | 1 | 2020 | 14 | 0.050 |
Why?
|
Recycling | 1 | 2020 | 17 | 0.050 |
Why?
|
Communication Barriers | 1 | 2024 | 398 | 0.050 |
Why?
|
Disease Management | 1 | 2011 | 2459 | 0.050 |
Why?
|
Equipment Reuse | 1 | 2020 | 41 | 0.050 |
Why?
|
Blood Pressure | 2 | 2014 | 8554 | 0.050 |
Why?
|
El Salvador | 1 | 2019 | 39 | 0.040 |
Why?
|
Movement | 1 | 2007 | 1471 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4251 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2593 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 56430 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19905 | 0.040 |
Why?
|
Anesthesia | 1 | 2010 | 1561 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14722 | 0.040 |
Why?
|
United States | 5 | 2021 | 69872 | 0.040 |
Why?
|
Africa, Western | 1 | 2019 | 154 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2012 | 3265 | 0.040 |
Why?
|
Patient Isolation | 1 | 2019 | 100 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2020 | 281 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6196 | 0.040 |
Why?
|
Recovery of Function | 1 | 2008 | 2925 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 541 | 0.040 |
Why?
|
Regional Medical Programs | 1 | 2016 | 71 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2008 | 14557 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2132 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2902 | 0.030 |
Why?
|
Ecuador | 1 | 2014 | 55 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 72290 | 0.030 |
Why?
|
Video Recording | 1 | 2019 | 949 | 0.030 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2015 | 102 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2015 | 292 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2016 | 352 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7279 | 0.030 |
Why?
|
Educational Measurement | 1 | 2019 | 1210 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3339 | 0.030 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 633 | 0.020 |
Why?
|
Tissue Donors | 2 | 2015 | 2240 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6489 | 0.020 |
Why?
|
Clinical Competence | 2 | 2019 | 4687 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2015 | 598 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2214 | 0.020 |
Why?
|
Personnel, Hospital | 1 | 2012 | 283 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2886 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 13881 | 0.020 |
Why?
|
Alamethicin | 1 | 1988 | 2 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2015 | 780 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8642 | 0.020 |
Why?
|
Massachusetts | 2 | 2012 | 8663 | 0.020 |
Why?
|
Respiration | 1 | 2015 | 1653 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18029 | 0.020 |
Why?
|
Patient Admission | 1 | 2016 | 1380 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40561 | 0.020 |
Why?
|
Electric Conductivity | 1 | 1988 | 411 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3493 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 63114 | 0.020 |
Why?
|
Lipid Bilayers | 1 | 1988 | 381 | 0.020 |
Why?
|
Postoperative Period | 1 | 2011 | 1842 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13408 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
Electrodes | 1 | 1988 | 619 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17446 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4933 | 0.020 |
Why?
|
Congenital Abnormalities | 1 | 2010 | 707 | 0.020 |
Why?
|
Safety Management | 1 | 2011 | 783 | 0.020 |
Why?
|
Surface Properties | 1 | 1988 | 1184 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2488 | 0.020 |
Why?
|
Maze Learning | 1 | 2007 | 478 | 0.020 |
Why?
|
Calcium Channels | 1 | 1988 | 622 | 0.020 |
Why?
|
Registries | 1 | 2020 | 8089 | 0.020 |
Why?
|
Health Personnel | 1 | 2017 | 3218 | 0.010 |
Why?
|
Mice | 2 | 2008 | 81183 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3528 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
Cattle | 1 | 1988 | 3922 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39050 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1105 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.010 |
Why?
|
Animals | 3 | 2008 | 168757 | 0.010 |
Why?
|
Ligands | 1 | 1988 | 3282 | 0.010 |
Why?
|
Equipment Design | 1 | 1988 | 3582 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6309 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2004 | 1850 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1988 | 2866 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1901 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 213383 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2007 | 11366 | 0.010 |
Why?
|
Inflammation | 1 | 2007 | 10638 | 0.000 |
Why?
|